Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 3/20 | 0.63 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.63 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.63 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.63 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.63 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.63 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.63 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.63 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.63 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.63 |
| ▸ | MAOB | P27338 | 8/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.54 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL404592 | 1.00 | HDAC3 (0.63) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| Maleic Acid SCHEMBL28010782 | 0.94 | HDAC3 (0.59) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| Butadiene SCHEMBL6735917 | 0.93 | HDAC3 (0.56) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| Acrylic Acid SCHEMBL27861204 | 0.91 | HDAC3 (0.54) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| SCHEMBL13067862 | 0.89 | HDAC2 (0.54) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| Methacrylic Acid SCHEMBL10791017 | 0.88 | HDAC3 (0.51) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| Acrylonitrile SCHEMBL5153154 | 0.87 | MCL1 (0.51) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| Maleic Anhydride SCHEMBL27994783 | 0.87 | HDAC3 (0.50) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| SCHEMBL11411205 | 0.87 | HDAC3 (0.50) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| Juarezic Acid SCHEMBL28990093 | 0.86 | HDAC3 (0.63) | HDAC3HDAC4HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160161475-A1 | HYBRID SEMICONDUCTING POLYMER NANOPARTICLES AS POLARIZATION-SENSITIVE FLUORESCENT PROBES | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION | 2016-06-09 | — | — | US | claimed |
| EP-3019443-A1 | HYBRID SEMICONDUCTING POLYMER NANOPARTICLES AS POLARIZATION SENSITIVE FLUORESCENT PROBES | University Of Washington Through Its Center For Commercialization (US) | 2016-05-18 | — | — | EP | claimed |
| US-20160018405-A1 | METHODS AND SYSTEMS FOR ANALYSIS USING POLYMER DOTS | University of Washington Through it's Center for Commercialization (US) | 2016-01-21 | — | — | US | claimed |
| US-20120161101-A1 | WATER STABLE III-V SEMICONDUCTOR NANOCRYSTAL COMPLEXES AND METHODS OF MAKING SAME | SAMSUNG ELECTRONICS CO., LTD (KR) | 2012-06-28 | — | — | US | claimed |
| US-6872450-B2 | Water-stable photoluminescent semiconductor nanocrystal complexes and method of making same | EVIDENT TECHNOLOGIES (US) | 2005-03-29 | — | — | US | claimed |
| US-20040115817-A1 | Water-stable photoluminescent semiconductor nanocrystal complexes and method of making same | EVIDENT TECHNOLOGIES, INC. | 2004-06-17 | — | — | US | claimed |
| EP-3019443-B1 | HYBRID SEMICONDUCTING POLYMER NANOPARTICLES AS POLARIZATION SENSITIVE FLUORESCENT PROBES | UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2026-02-25 | — | — | EP | disclosed |
| US-20260014561-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | UNIV WASHINGTON (US) | 2026-01-15 | — | — | US | disclosed |
| US-12447469-B2 | Methods and apparatus for single biological nanoparticle analysis | UNIVERSITY OF WASHINGTON (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250290930-A1 | FUNCTIONALIZED CHROMOPHORIC POLYMER DOTS AND BIOCONJUGATES THEREOF | CLEMSON UNIVERSITY RESEARCH FOUNDATION | 2025-09-18 | — | — | US | disclosed |
| EP-3483610-B1 | FUNCTIONALIZED CHROMOPHORIC POLYMER DOTS AND BIOCONJUGATES THEREOF | UNIV OF WASHINGTON CENTER FOR COMMERCIALIZATION (US) | 2025-09-10 | — | — | EP | disclosed |
| US-12352754-B2 | Functionalized chromophoric polymer dots and bioconjugates thereof | UNIVERSITY OF WASHINGTON (US) | 2025-07-08 | — | — | US | disclosed |
| CN-112105912-B | Method and apparatus for single biological nanoparticle analysis | 华盛顿大学 | 2025-05-23 | — | — | CN | disclosed |
| US-20050136258-A1 | Nanoparticle fluorescent probes comprised of quantum dot and hydrophobic protection structure including capping ligand and amphiphilic copolymer; biocompatibility; multiplexed imaging and detection of genes and proteins in single living cells; cancer diagnosis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-06-23 | — | — | US | disclosed |
| US-6872450-B2 | Water-stable photoluminescent semiconductor nanocrystal complexes and method of making same | EVIDENT TECHNOLOGIES (US) | 2005-03-29 | — | — | US | disclosed |
| EP-1493015-A1 | ANALYTE SENSOR | Powerzyme, Inc. (US) | 2005-01-05 | — | — | EP | disclosed |
| US-20040115817-A1 | Water-stable photoluminescent semiconductor nanocrystal complexes and method of making same | EVIDENT TECHNOLOGIES, INC. | 2004-06-17 | — | — | US | disclosed |
| US-20030228681-A1 | Analyte sensor | POWERZYME, INC. | 2003-12-11 | — | — | US | disclosed |
| WO-2003087783-A1 | ANALYTE SENSOR | POWERZYME, INC. (US) | 2003-10-23 | — | — | WO | disclosed |
| WO-1997000249-A1 | HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014561-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | CD63, SELL, LAMP2 | HDAC3 2808/4885HDAC4 4325/4885HDAC1 3391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.